Therapeutic impact of epidermal growth factor receptor tyrosine kinase inhibitor with various treatment combinations for advanced lung adenocarcinoma.

Authors:
Chen YY; Lin KH; Kuo YS; Tsai YM; Huang HK and 1 more

Journal:
World J Surg Oncol

Publication Year: 2023

DOI:
10.1186/s12957-023-03203-6

PMCID:
PMC10571456

PMID:
37833769

Journal Information

Full Title: World J Surg Oncol

Abbreviation: World J Surg Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: General Surgery

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the Institutional Review Board/Ethics Committee of Tri-Service General Hospital (C202105025). Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This research was supported by the Medical Civic Action Program (TSGH-C01-111023, TSGH-C02-110021, TSGH-C03-109027) of the Medical Research Development Fund and Lung Cancer Registry Group, Tri-Service General Hospital."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025